SAREPTA THERAPEUTICS, INC. Inventory, Finished Goods, Net of Reserves
SAREPTA THERAPEUTICS, INC. (SRPT) had Inventory, Finished Goods, Net of Reserves of $56.17 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $56.17M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $57.98M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $65.32M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $64.80M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $56.17M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $57.98M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $65.32M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $64.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $70.98M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $61.37M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $47.21M 10-K · filed 2026-03-02 |
| 2024-09-30 | $77.98M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $52.90M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $39.50M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $61.81M 10-K · filed 2025-02-28 |
| 2023-09-30 | $47.24M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $47.61M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $42.69M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $38.15M 10-K · filed 2024-02-28 |
| 2022-09-30 | $49.26M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $35.50M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $33.88M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $26.72M 10-K · filed 2023-02-28 |
| 2021-09-30 | $26.83M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $29.47M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $28.28M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $20.54M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.55M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.62M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $6.91M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.32M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.79M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $6.09M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.31M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $6.85M 10-K · filed 2020-02-26 |
| 2018-09-30 | $4.59M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $2.49M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.27M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $2.29M 10-K · filed 2019-02-28 |
| 2017-09-30 | $292.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $160.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $114.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $107.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $209.00K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |